AngioDynamics, Inc. (ANGO)
15.95
+0.18
(+1.14%)
USD |
NASDAQ |
Aug 25, 16:00
15.95
0.00 (0.00%)
After-Hours: 19:59
AngioDynamics Cash from Operations (Quarterly) : 17.45M for May 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 17.45M |
| February 28, 2026 | -3.11M |
| November 30, 2025 | 4.661M |
| August 31, 2025 | -15.91M |
| May 31, 2025 | 18.13M |
| February 28, 2025 | -13.16M |
| November 30, 2024 | 2.473M |
| August 31, 2024 | -18.25M |
| May 31, 2024 | 5.001M |
| February 29, 2024 | -12.53M |
| November 30, 2023 | 5.266M |
| August 31, 2023 | -25.90M |
| May 31, 2023 | 16.70M |
| February 28, 2023 | 1.37M |
| November 30, 2022 | 7.454M |
| August 31, 2022 | -25.45M |
| May 31, 2022 | 8.56M |
| February 28, 2022 | -8.791M |
| November 30, 2021 | 1.941M |
| August 31, 2021 | -8.904M |
| May 31, 2021 | 12.20M |
| February 28, 2021 | 5.871M |
| November 30, 2020 | 11.45M |
| August 31, 2020 | -5.425M |
| May 31, 2020 | 3.88M |
| Date | Value |
|---|---|
| February 29, 2020 | -17.10M |
| November 30, 2019 | 5.937M |
| August 31, 2019 | -7.275M |
| May 31, 2019 | 25.01M |
| February 28, 2019 | 8.342M |
| November 30, 2018 | 12.96M |
| August 31, 2018 | -8.873M |
| May 31, 2018 | 23.77M |
| February 28, 2018 | 4.315M |
| November 30, 2017 | 10.16M |
| August 31, 2017 | 3.036M |
| May 31, 2017 | 18.99M |
| February 28, 2017 | 14.36M |
| November 30, 2016 | 14.95M |
| August 31, 2016 | 7.44M |
| May 31, 2016 | 18.54M |
| February 29, 2016 | 12.39M |
| November 30, 2015 | 9.579M |
| August 31, 2015 | 4.699M |
| May 31, 2015 | 10.81M |
| February 28, 2015 | 12.23M |
| November 30, 2014 | -2.147M |
| August 31, 2014 | 5.352M |
| May 31, 2014 | 9.507M |
| February 28, 2014 | -0.584M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.474B |
| Penumbra, Inc. | 46.08M |
| Abbott Laboratories | 2.488B |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.27M |
| Cash from Financing (Quarterly) | -0.108M |
| Free Cash Flow | -2.86M |
| Free Cash Flow Per Share (Quarterly) | 0.3881 |
| Free Cash Flow to Equity (Quarterly) | 16.62M |
| Free Cash Flow to Firm (Quarterly) | 16.29M |
| Free Cash Flow Yield | -0.43% |